TEPEZZAHCP.COM: Keyword Density Checker

Total words: 5630 | 2-word phrases: 1490 | 3-word phrases: 1679 | 4-word phrases: 1756

PAGE INFO

Title	Try to keep the title under 60 characters (54 characters) TEPEZZA® (teprotumumab-trbw) TED Treatment \| HCP Home
Description	Try to keep the meta description between 50 - 160 characters (197 characters) Find healthcare professional information on TEPEZZA® (teprotumumab-trbw), indicated to treat Thyroid Eye Disease (TED) regardless of disease activity or duration. See Important Safety Information.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (43 characters) REGARDLESS OF DISEASE ACTIVITY OR DURATION1

#	Keyword	Frequency	Density
1	thyroid eye disease	18	1.07%
2	tepezza may cause	9	0.54%
3	the treatment of	8	0.48%
4	of thyroid eye	7	0.42%
5	important safety information	6	0.36%
6	inflammatory bowel disease	6	0.36%
7	preexisting inflammatory bowel	6	0.36%
8	tepezza patient resources	6	0.36%
9	eye disease a	6	0.36%
10	hearing impairment including	6	0.36%
11	impairment including hearing	6	0.36%
12	including hearing loss	6	0.36%
13	indicated for the	5	0.30%
14	full prescribing information	5	0.30%
15	treatment of thyroid	5	0.30%
16	disease activity or	5	0.30%
17	for the treatment	5	0.30%
18	patient resources icon	5	0.30%
19	terms and conditions	5	0.30%
20	activity or duration	4	0.24%
21	tepezza is indicated	4	0.24%
22	is indicated for	4	0.24%
23	and consider the	3	0.18%
24	10 of patients	3	0.18%
25	increased blood glucose	3	0.18%
26	blood glucose or	3	0.18%
27	common adverse reactions	3	0.18%
28	most common adverse	3	0.18%
29	glucose or hyperglycemia	3	0.18%
30	or hyperglycemia may	3	0.18%

#	Keyword	Frequency	Density
1	of thyroid eye disease	7	0.40%
2	impairment including hearing loss	6	0.34%
3	hearing impairment including hearing	6	0.34%
4	preexisting inflammatory bowel disease	6	0.34%
5	the treatment of thyroid	5	0.28%
6	for the treatment of	5	0.28%
7	indicated for the treatment	5	0.28%
8	thyroid eye disease a	5	0.28%
9	treatment of thyroid eye	4	0.23%
10	is indicated for the	4	0.23%
11	tepezza is indicated for	4	0.23%
12	disease activity or duration	4	0.23%
13	some cases may be	3	0.17%
14	permanent assess patients’ hearing	3	0.17%
15	inflammatory bowel disease ibd	3	0.17%
16	bowel disease ibd monitor	3	0.17%
17	within 15 hours after	3	0.17%
18	in some cases may	3	0.17%
19	loss which in some	3	0.17%
20	hearing loss which in	3	0.17%
21	including hearing loss which	3	0.17%
22	patients with ibd for	3	0.17%
23	tepezza may cause severe	3	0.17%
24	loss tepezza may cause	3	0.17%
25	hearing loss tepezza may	3	0.17%
26	including hearing loss tepezza	3	0.17%
27	with ibd for flare	3	0.17%
28	ibd for flare of	3	0.17%
29	for flare of disease	3	0.17%
30	which in some cases	3	0.17%
31	assess patients’ hearing before	3	0.17%
32	before and while receiving	3	0.17%
33	bowel disease tepezza may cause	3	0.17%
34	at a slower infusion	3	0.17%
35	preexisting inflammatory bowel disease tepezza	3	0.17%
36	≥5 and greater than	3	0.17%
37	incidence ≥5 and greater	3	0.17%
38	reactions incidence ≥5 and	3	0.17%
39	adverse reactions incidence ≥5	3	0.17%
40	common adverse reactions incidence	3	0.17%

#	URL	Whois	Check
1	https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf	Whois	hzndocs.com
2	https://www.tepezza.com	Whois	tepezza.com
3	https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf	Whois	hzndocs.com
4	https://www.hzndocs.com/TEPEZZA-Patient-Enrollment-Form.pdf	Whois	hzndocs.com
5	https://www.hzndocs.com/TEPEZZA-Patient-Enrollment-Form.pdf	Whois	hzndocs.com
6	https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf	Whois	hzndocs.com
7	https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-announces-positive-topline-data	Whois	horizontherapeutics.com
8	https://www.hzndocs.com/TEPEZZA-Patient-Enrollment-Form.pdf	Whois	hzndocs.com
9	https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf	Whois	hzndocs.com
10	https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf	Whois	hzndocs.com
11	https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf	Whois	hzndocs.com
12	https://www.amgen.com/	Whois	amgen.com
13	https://www.horizontherapeutics.com/legal/legal-notice	Whois	horizontherapeutics.com
14	https://www.horizontherapeutics.com/legal/privacy-policy	Whois	horizontherapeutics.com
15	https://www.horizontherapeutics.com/legal/cookie-policy	Whois	horizontherapeutics.com
16	https://www.horizontherapeutics.com/company/contact	Whois	horizontherapeutics.com
17	https://www.horizontherapeutics.com/medicines/medicine-support	Whois	horizontherapeutics.com
18	https://www.amgen.com/	Whois	amgen.com
19	https://userway.org	Whois	userway.org